Quick Answer
NOVARTIS AG reported Total Assets of $110.95 billion for fiscal year 2025.
NOVARTIS AG Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $110.95B | +8.5% |
| 2024 | $102.25B | +2.3% |
| 2023 | $99.94B | -14.9% |
| 2022 | $117.45B | -10.9% |
| 2021 | $131.79B | +3.1% |
| 2020 | $127.78B | +7.9% |
| 2019 | $118.37B | -18.7% |
| 2018 | $145.56B | +9.4% |
| 2017 | $133.08B | — |
- NOVARTIS AG showed an increase of +8.5% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, NOVARTIS AG’s total assets has declined by 16.6% (from $133.08 billion to $110.95 billion).
- The most recent figure is from NOVARTIS AG’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: